impress oper execut continu even face
remain overweight rate share impress manag
team execut abil compani post see strong high-qual
beat despit meaning disrupt physician practic across globe
maintain guidanc put take environ
inevit find impress maintain top- bottom-lin guidanc
combin number key pipelin updat tap notabl pivot
data nsclc year think share continu work rais price target
remain buyer
high qualiti report top- bottom-lin beat total revenu
vs consensu psc non-gaap ep vs
consensus/psc put take across commerci portfolio includ
beat biosimilar repatha otezla respect
miss aimovig manag re-affirmed revenu consensu
non-gaap ep guidanc consensu
stand spherix survey work predict big time disrupt
anyon manag spherix survey feedback consist
indic sever neg impact prescrib trend across
mani specialti though limit impact amgn result fact
tailwind relat earli script refil expect see
impact come quarter inde slowdown busi rest year
impli unchang guidanc rang despit revenu
ep beat didnt provid much commentari specif think
compani focu home administr telemedicin physician support
seem act meaning countermeasur liter biggest disrupt
physician practic seen lifetim would view maintain guidanc
victori given circumst
multipl pipelin updat tap includ pivot
nsclc data tezepelumab asthma data think share continu
work mani move part model trim bone health rais repatha
biosimilar ep come reflect
headwind out-year ep modestli higher
higher ep coupl partial laps
discount period bring target remain buyer
global biopharmaceut compani
ep discount
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
page
good sold
product sale
total revenu
sell gener administr
total revenu
statement oper
dollar except per share data
provis incom tax tax benefit
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
page
total aimovig revenu
dollar except per share data
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
